Slotkin, E. K., Patwardhan, P. P., Vasudeva, S. D., de Stanchina, E., Tap, W. D., & Schwartz, G. K. (2014). MLN0128, an ATP-Competitive mTOR Kinase Inhibitor, with Potent In vitro and In vivo Antitumor Activity as Potential Therapy for Bone and Soft-Tissue Sarcoma. Mol Cancer Ther.
Dyfyniad Arddull ChicagoSlotkin, Emily K., Parag P. Patwardhan, Shyamprasad Deraje Vasudeva, Elisa de Stanchina, William D. Tap, and Gary K. Schwartz. "MLN0128, an ATP-Competitive MTOR Kinase Inhibitor, With Potent In Vitro and In Vivo Antitumor Activity As Potential Therapy for Bone and Soft-Tissue Sarcoma." Mol Cancer Ther 2014.
Dyfyniad MLASlotkin, Emily K., et al. "MLN0128, an ATP-Competitive MTOR Kinase Inhibitor, With Potent In Vitro and In Vivo Antitumor Activity As Potential Therapy for Bone and Soft-Tissue Sarcoma." Mol Cancer Ther 2014.